Stay updated on Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page.

Latest updates to the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page
- ChecktodayChange DetectedThe page’s footer software version was updated from “Revision: v3.5.0” to “Revision: v3.5.3.”SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0. The change appears to be a system version update without modifications to study data or page content.SummaryDifference0.0%

- Check50 days agoChange DetectedThe site revision was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2 with no visible changes to study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check79 days agoChange DetectedThe update shows a revision from v3.4.0 to v3.4.1, with no changes to the study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check93 days agoChange DetectedAdded Show glossary and Hide glossary options and updated metadata labels to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.3%

Stay in the know with updates to Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page.